Kerollos N. Wanis

Mar 21, 2023 | onlinelibrary.wiley.com | Aaron L. Sarvet |Kerollos N. Wanis |Jessica Young |Roberto Hernandez-Alejandro

1 INTRODUCTION When first-line treatments are scarce, patients often face decisions between waiting for a suspected superior treatment or accepting the first available treatment. For example, many patients with end-stage liver disease will reject transplantation with “increased risk” liver grafts (Kumar et al., 2016), which are suspected to confer a higher risk of unintended transmission of HIV, hepatitis B, and/or hepatitis C (Seem et al., 2013).